Author(s):
Bipasha Behera, Uma Shankar Mishra, Sudhir Kumar Sahoo
Email(s):
nootadivya13@gmail.com
DOI:
10.52711/0974-360X.2023.00707 
Address:
Bipasha Behera1*, Uma Shankar Mishra2, Sudhir Kumar Sahoo3
1Institute of Pharmacy and Technology, Salpur, Dist. Cuttack, Orissa, India – 754202.
2,3Royal College of Pharmacy and Health Sciences, Andhapasara Road, Berhampur, Dist: Ganjam, Odisha, India – 760002.
*Corresponding Author
Published In:
Volume - 16,
Issue - 9,
Year - 2023
ABSTRACT:
The objective of the present research work was to develop an innovative, simple, and economic method for estimation of Vilazodone in bulk and dosage form by RP-HPLC. The chromatographic conditions were performed on Phenomenex Luna C18, 100A, 5µm, 250mm x 4.6mm i.d.as stationary phase and mobile phase was prepared with a mixture of Phosphate Buffer: Acetonitrile = 30:70 (pH-7.6) flow 1.0ml/min, with Injection Volume 20µl, at detection wavelength 238nm and run time at 8.0 min.The analytical method is validated for estimation of vilazodone over a range of 06µg/ml–16µg/ml. The results of system suitability test, linearity, precision and accuracy, robustness, specificity, LOD and LOQ and stabilities presented in this report are within the acceptance range.A specific, sensitive, economic method estimation of vilazodone has been developed based on ICH Guidelines with bulk and dosage forms.
Cite this article:
Bipasha Behera, Uma Shankar Mishra, Sudhir Kumar Sahoo, Development and Validation of Stability Indicating RP-HPLC Method for The Analysis of Vilazodone in Bulk form and Marketed Pharmaceutical Dosage Form, Research Journal of Pharmacy and Technology 2023; 16(9):4319-4. doi: 10.52711/0974-360X.2023.00707
Cite(Electronic):
Bipasha Behera, Uma Shankar Mishra, Sudhir Kumar Sahoo, Development and Validation of Stability Indicating RP-HPLC Method for The Analysis of Vilazodone in Bulk form and Marketed Pharmaceutical Dosage Form, Research Journal of Pharmacy and Technology 2023; 16(9):4319-4. doi: 10.52711/0974-360X.2023.00707 Available on: https://rjptonline.org/AbstractView.aspx?PID=2023-16-9-51
REFERENCES:
1. L. R. Snyder, J.J. Kirkland, and J. W. Dolan, Introduction to Modern Liquid Chromatography, John Wiley and Sons, New York, 2009.
2. M.W. Dong, Modern HPLC for Practicing Scientists, Wiley, 2006.
3. L. R. Snyder, J.J. Kirkland, and J. L. Glajch, Practical HPLC Method Development, John Wiley and Sons, New York, 1997.
4. S. Ahuja and H. T. Rasmussen (Ed), HPLC Method Development for Pharmaceuticals, Academic Press, 2007.
5. S. Ahuja and M.W. Dong (Ed), Handbook of Pharmaceutical Analysis by HPLC, Elsevier/Academic Press, 2005.
6. ICH Harmonized Tripartite Guideline, Q1F: Stability Data Package for Registration Application in Climate Zones III and IV, London: 2003.
7. "FDA approves Clinical Data Inc's antidepressant". Reuters. January 22, 2011. Archived from the original on January 27, 2011.
8. "FDA approves Clinical Data Inc's antidepressant". Reuters. January 22, 2011, Archived from the original on 27 January 2011, Retrieved 12 April 2014.
9. "Clinical Data, Inc. - Clinical Data, Inc. Submits New Drug Application for Vilazodone for the Treatment of Major Depressive Disorder", Archived from the original on 18 August 2011, Retrieved 12 April 2014.
10. Khan A, Cutler AJ, Kajdasz DK, Gallipoli S, Athanasiou M, Robinson DS, Whalen H, Reed CR: A randomized, double-blind, placebo-controlled, 8-week study of vilazodone, a serotonergic agent for the treatment of major depressive disorder, J Clin Psychiatry, 2011 Apr; 72 (4):441-7. Doi: 10.4088/JCP.10m06596.
11. Traynor K: Vilazodone approved for major depression. Am J Health Syst Pharm. 2011 ; 68 (5):366. Doi: 10.2146/news110009.
12. Howland RH: Vilazodone: another novel atypical antidepressant drug. J Psychosoc Nurs Ment Health Serv. 2011; 49 (3): 19-22. Doi: 10.3928/02793695-20110203-98. Epub 2011 Feb 16.
13. Dawson LA, Watson JM: Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders. CNS Neurosci Ther. 2009 ; 15 (2): 107-17.
14. De Paulis T: Drug evaluation: Vilazodone--a combined SSRI and 5-HT1A partial agonist for the treatment of depression. I Drugs. 2007 ; 10 (3): 193-201.
15. Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I: Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist, J Pharmacol Exp Ther. 2002 ; 302 (3): 1220-7.
16. Wang SM, Han C, Lee SJ, Patkar AA, Masand PS, Pae CU: A review of current evidence for vilazodone in major depressive disorder, Int J Psychiatry Clin Pract, 2013; 17(3): 160-9. Doi: 10.3109/13651501.2013.794245. Epub 2013 May 29.
17. Dopheide JA: Vilazodone's comparative merits yet to be demonstrated. Am J Health Syst Pharm. 2012; 69 (18): 1549. Doi: 10.2146/ajhp110570.
18. Thangabalan B, Lakshmi Narusu R, Syedali Fathima SK and Manohar Babu S. RP-HPLC method development and validation of Vilazodone in pure and tablet dosage form. International Journal of Novel Trends in Pharmaceutical Sciences. 2015; 5(2): 25-26.
19. Somsubhra Ghosh, S. Venkatesh, B. V. V. Ravikumar. Development of Stability Indicating RP-HPLC Method and Validation for the Estimation of Vilazodone Hydrochloride. International Journal of PharmTech Research. 2015;7(1):204-211.
20. P. Ravisankar, S. Gowthami, CH. Devadasu, P. Srinivasa Babu, P. Venkateswar Reddy. A Novel Validated RP HPLC Method for the Estimation of Vilazodone in Bulk and Pharmaceutical Dosage Form. American Journal of PharmTech Research. 2014; 4(5): 670-682.
21. Sagar Suman Panda, Venkata Varaha Bera Ravi Kumar, Sarwar Beg, Sunil Kumar Sahu, and Swayamprabha Muni. Development and Validation of a Stability Indicating Liquid Chromatographic Method for Estimating Vilazodone Hydrochloride in Pharmaceutical Dosage Form Using Quality by Design. Journal of Chromatographic Science. 2016; 54(10): 1713–1722.
22. Vivekkumar K Redasani, Sanjay J Surana. Development and Validation of Vilazodone HCl by RP-HPLC In Bulk and in Pharmaceutical Formulation Along with its Application in Dissolution. International Journal of Analytical Techniques. 3(1): 1-7.
23. Mukthinuthalapati Mathrusri Annapurna, Kunala Anusha, Afreen Shahena Sharief, Varanasi Sindhuri. New validated RP-HPLC method for the determination of Vilazodone hydrochloride – A serotonergic Anti-depressant. Research Journal of Pharmacy and Technology. 2017; 10 (4): 1077-1080.
24. Venkata Subbaiah, G, Devika, G.S, R. Salibai, K. Hemalatha, S.V Gopala Krishna. Determination of vilazodone in pharmaceutical formulations by HPLC method. Journal of Global Trends in Pharmaceutical Sciences. 2014; 5(4): 2261–2264.
25. Dewi Sulthoniyah, Riesta Primaharinastiti, Febri Annuryanti. Method Validation of Flame Atomic Absorption Spectrophotometry (FAAS) for Determination of Iron (FE) in Multivitamin Mineral Capsule Dosage Form. Research J. Pharm. and Tech. 2018; 11(6): 2569-2574
26. Omer Jasim Mohammed, Mohammed Jassim Hamzah, Ahmed Mahdi Saeed. RP–HPLC Method Validation for Simultaneous Estimation of Paracetamol and Caffeine in Formulating Pharmaceutical Form. Research Journal of Pharmacy and Technology. 2021; 14(9):4743-8.
27. Vitthal M. Dhalape, Santosh T. Khadangale, Rahul V. Pinjari. RP-HPLC Method Validation for Quantitative Analysis of Pemetrexed Disodium Hemipentahydrate. Research J. Pharm. and Tech. 2020; 13(8): 3685-3689.
28. B. Siddartha, Sudheer Babu, C. Parthiban, Prathyusha V. Method Development and Method Validation of Tinidazole in Bulk and Pharmaceutical Dosage Form by UV– Spectrophotometric Method. Research J. Pharm. and Tech. 2014; 7(4): 467-469.
29. Mohammed M Hussain, Nappinai M. Development and Method Validation of an Unconventional In-Vitro Test To Measure Mucoadhesive Strength of Tablets. Research J. Pharm. and Tech. 2009; 2 (2).
30. J. Nageswara Rao, Ch. Sudhakar, Som Shankar Dubey. RP-HPLC Method Validation for the Assay of Tenofovir Disoproxil Orotate. Research Journal of Pharmacy and Technology. 2021; 14(7):3855-9
31. Kanchan Nikam, Sachin Bhusari, Pravin Wakte. High Performance Liquid Chromatography Method Validation and Forced degradation Studies of Pterostilbene. Research Journal of Pharmacy and Technology. 2022; 15(7):2969-5.
32. Vyas N, Panchal S. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Nebivolol and Indapamide in Pharmaceutical Dosage Form. Asian J. Pharm. Ana. 2014; 4(3):98-102.
33. Revathi R, Venkata Naga Suresh P, Koteswara Rao M, Ethiraj T, Rajarajan S. Development and Validation of RP-HPLC Method for Content Analysis of Didanosine in Dosage Form. Asian J. Pharm. Ana. 2012; 2(4):118-121.
34. Swapna J, Madhu C, Srivani M, Sumalatha M, Nehalatha Y, Anusha Y. Analytical Method Development and Method Validation for the Simultaneous Estimation of Metformin hydrochloride and Pioglitazone hydrochloride in Tablet Dosage Form by RP-HPLC. Asian J. Pharm. Ana. 2012; 2(3): 85-89.